(EMAILWIRE.COM, November 20, 2009 ) Dallas, TX - VIVUS, Inc. (NASDAQ:VVUS) fell 4.90% to end the day at $8.34. So far this year, the stock has rallied over 55%. VIVUS, Inc. is a pharmaceutical company focused on the development and commercialization of therapeutic products. The Company’s product pipeline includes three late-stage clinical products, each addressing specific components of the obesity, diabetes and sexual health markets.

CEL-SCI Corporation (AMEX:CVM) decreased 4.44% to close at $1.29. The stock has recovered over 800% from its 52-week low of $0.14. CEL-SCI Corporation, is engaged in the development of a product called Multikine for the treatment of cancer. It simulates the activities of a healthy person's immune system, which battles cancer every day.

Incyte Corporation (NASDAQ:INCY) decreased 4.69% to $7.72. So far this year, the stock price has doubled. Incyte Corporation (Incyte) is a drug discovery and development company focused on developing small molecule drugs to treat serious unmet medical needs. The Company has a pipeline with programs in oncology, inflammation and diabetes.

ABOUT http://www.PennyStockPickalert.com

The website alerts investors on Top Stocks that would help investors to generate higher than average returns. These include various types of stocks with huge volume, penny stocks that are moving to the upside quickly, penny stocks with buy signals and companies with news. Our regular Stock pick Alerts helps investors to achieve incredible results in a short amount of time .If you wish to get your company featured on our website then please contact us at info @PennyStockPickReport

Contact Information:
PennyStockPickAlert.com
Robert Wilson
Tel: 214 556 6798
Email us


This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.